等待開盤 05-22 09:30:00 美东时间
+0.030
+0.73%
Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the "Board") has thoroughly reviewed and unanimously rejected the further
今天 04:40
Beta Bionics, Inc. (NASDAQ:BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it expects to fully commercialize Mint by the end of the second quarter of 2027,
今天 04:05
Zscaler, Inc. (NASDAQ: ZS), the cybersecurity platform for the AI era, today announced the intent to acquire Symmetry Systems, Inc., a pioneer in identity mapping and data access for AI security. Symmetry Systems' access
05-21 20:03
Today, IBM (NYSE:IBM) and the U.S. Department of Commerce (DoC) announced a Letter of Intent (LOI) to build an American quantum chip foundry, securing the nation's global quantum leadership and fueling the country's
05-21 18:51
CAVA stock surges 7.49% premarket after crushing Q1 estimates, reporting $438.27M in revenue, and raising its full-year 2026 outlook.
05-20 17:56
Skillz (NYSE:SKLZ) reported first-quarter financial results on Tuesday. The tra...
05-20 13:51
Virgin Galactic shares are trading lower Tuesday afternoon as traders weigh cash burn and liquidity concerns against the company's flight-test timeline.
05-20 04:05
The latest update is out from Oncopeptides AB ( ($SE:ONCO) ). Oncopeptides has ...
05-19 23:04
Northrop Grumman Corporation announced a quarterly dividend of $2.47 per share, payable on June 17, 2026, to shareholders of record as of June 1, 2026. The company continues to focus on its capital allocation strategy, prioritizing investments in manufacturing capabilities and technologies for customers. Northrop Grumman is a global leader in aerospace and defense technology, providing innovative solutions to connect, protect, and explore the uni...
05-19 21:08
Kura Oncology will participate in the TD Cowen 7th Annual Oncology Innovation Summit on May 26, 2026, with a virtual fireside chat at 1:30 p.m. ET. The event will be available live and on replay via the company’s website. Kura Oncology focuses on precision medicines for cancer, with a pipeline targeting hematologic malignancies and solid tumors. The company has developed KOMZIFTI™, an FDA-approved menin inhibitor for relapsed or refractory NPM1-m...
05-19 20:02